This is a preview of subscription content, log in via an institution to check access.
Notes
The study was partially funded by Werfen.
Reference
Moroni L, et al. Economic Impact Analysis of the Use of Anti-DFS70 Antibody Test In Patients with Undifferentiated Systemic Autoimmune Disease Symptoms. The Journal of Rheumatology : Nov 2019. Available from: URL: http://doi.org/10.3899/jrheum.190533
Rights and permissions
About this article
Cite this article
DFS70 assay in suspected autoimmune disease saves cost. PharmacoEcon Outcomes News 841, 15 (2019). https://doi.org/10.1007/s40274-019-6367-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-019-6367-7